[2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc

C296H296N40O6S2Zn5-4 — CID 157141553

About [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc

[2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc (PubChem CID 157141553) has the molecular formula C296H296N40O6S2Zn5-4 and a molecular weight of 4900.98 g/mol. Its IUPAC name is [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc.

Molecular Properties

• Compound Name: [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc
• PubChem CID: 157141553
• Molecular Formula: C296H296N40O6S2Zn5-4
• Molecular Weight: 4900.98 g/mol
• Exact Mass: 4890.00
• IUPAC Name: [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc
• SMILES: CC1(C)c2ccccc2N(c2ccc(-c3nc4ccccc4o3)c(O)c2)c2ccccc21.CC1=C(C)C(C)(C)C(C)=C(C)N1c1ccc(-c2nc3ccccc3o2)c(O)c1.CC1=C(C)N(c2ccc(-c3nc4ccccc4n3C)c(N)c2)C(C)=C(C)N1C.CC1=C(C)N(c2ccc(-c3nc4ccccc4n3C)c(N)c2)C(C)=C(C)N1c1ccccc1.CC1=C(C)N(c2ccc(-c3nc4ccccc4o3)c(N)c2)C(C)=C(C)N1C.CC1=C(C)N(c2ccc(-c3nc4ccccc4s3)c(N)c2)C(C)=C(C)N1C.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2n1-c1ccccc1.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2o1.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2s1.CCCCCCC[N-]c1cc(N2c3ccccc3N(c3ccccc3)c3ccccc32)ccc1-c1nc2ccccc2n1-c1ccccc1.[Zn].[Zn].[Zn].[Zn].[Zn]
• InChI: InChI=1S/C44H40N5.C39H38N5.C33H33N4O.C33H33N4S.C28H29N5.C28H22N2O2.C24H26N2O2.C23H27N5.C22H24N4O.C22H24N4S.5Zn/c1-2-3-4-5-18-31-45-38-32-35(29-30-36(38)44-46-37-23-12-13-24-39(37)49(44)34-21-10-7-11-22-34)48-42-27-16-14-25-40(42)47(33-19-8-6-9-20-33)41-26-15-17-28-43(41)48;1-3-4-5-6-16-27-40-33-28-30(43-37-23-14-12-21-35(37)42(2)36-22-13-15-24-38(36)43)25-26-31(33)39-41-32-19-10-11-20-34(32)44(39)29-17-8-7-9-18-29;2*1-3-4-5-6-13-22-34-27-23-24(20-21-25(27)33-35-26-14-7-12-19-32(26)38-33)37-30-17-10-8-15-28(30)36(2)29-16-9-11-18-31(29)37;1-18-20(3)33(21(4)19(2)32(18)22-11-7-6-8-12-22)23-15-16-24(25(29)17-23)28-30-26-13-9-10-14-27(26)31(28)5;1-28(2)20-9-3-6-12-23(20)30(24-13-7-4-10-21(24)28)18-15-16-19(25(31)17-18)27-29-22-11-5-8-14-26(22)32-27;1-14-16(3)26(17(4)15(2)24(14,5)6)18-11-12-19(21(27)13-18)23-25-20-9-7-8-10-22(20)28-23;1-14-16(3)28(17(4)15(2)26(14)5)18-11-12-19(20(24)13-18)23-25-21-9-7-8-10-22(21)27(23)6;2*1-13-15(3)26(16(4)14(2)25(13)5)17-10-11-18(19(23)12-17)22-24-20-8-6-7-9-21(20)27-22;;;;;/h6-17,19-30,32H,2-5,18,31H2,1H3;7-15,17-26,28H,3-6,16,27H2,1-2H3;2*7-12,14-21,23H,3-6,13,22H2,1-2H3;6-17H,29H2,1-5H3;3-17,31H,1-2H3;7-13,27H,1-6H3;7-13H,24H2,1-6H3;2*6-12H,23H2,1-5H3;;;;;/q4*-1
• InChIKey: YNVNPFDPCVPYKL-UHFFFAOYSA-N
• XLogP: 81.44
• TPSA: 460.44 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 44
• Rotatable Bonds: 52
• Heavy Atoms: 349
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	4900.98
LogP ≤ 5	81.44
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	44

Frequently Asked Questions

What is the IUPAC name of [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc?

The IUPAC name of [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc (CID 157141553) is [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc.

What is the SMILES notation for [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc?

The canonical SMILES for [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc is CC1(C)c2ccccc2N(c2ccc(-c3nc4ccccc4o3)c(O)c2)c2ccccc21.CC1=C(C)C(C)(C)C(C)=C(C)N1c1ccc(-c2nc3ccccc3o2)c(O)c1.CC1=C(C)N(c2ccc(-c3nc4ccccc4n3C)c(N)c2)C(C)=C(C)N1C.CC1=C(C)N(c2ccc(-c3nc4ccccc4n3C)c(N)c2)C(C)=C(C)N1c1ccccc1.CC1=C(C)N(c2ccc(-c3nc4ccccc4o3)c(N)c2)C(C)=C(C)N1C.CC1=C(C)N(c2ccc(-c3nc4ccccc4s3)c(N)c2)C(C)=C(C)N1C.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2n1-c1ccccc1.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2o1.CCCCCCC[N-]c1cc(N2c3ccccc3N(C)c3ccccc32)ccc1-c1nc2ccccc2s1.CCCCCCC[N-]c1cc(N2c3ccccc3N(c3ccccc3)c3ccccc32)ccc1-c1nc2ccccc2n1-c1ccccc1.[Zn].[Zn].[Zn].[Zn].[Zn].

What is the InChIKey of [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc?

The InChIKey is YNVNPFDPCVPYKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H40N5.C39H38N5.C33H33N4O.C33H33N4S.C28H29N5.C28H22N2O2.C24H26N2O2.C23H27N5.C22H24N4O.C22H24N4S.5Zn/c1-2-3-4-5-18-31-45-38-32-35(29-30-36(38)44-46-37-23-12-13-24-39(37)49(44)34-21-10-7-11-22-34)48-42-27-16-14-25-40(42)47(33-19-8-6-9-20-33)41-26-15-17-28-43(41)48;1-3-4-5-6-16-27-40-33-28-30(43-37-23-14-12-21-35(37)42(2)36-22-13-15-24-38(36)43)25-26-31(33)39-41-32-19-10-11-20-34(32)44(39)29-17-8-7-9-18-29;2*1-3-4-5-6-13-22-34-27-23-24(20-21-25(27)33-35-26-14-7-12-19-32(26)38-33)37-30-17-10-8-15-28(30)36(2)29-16-9-11-18-31(29)37;1-18-20(3)33(21(4)19(2)32(18)22-11-7-6-8-12-22)23-15-16-24(25(29)17-23)28-30-26-13-9-10-14-27(26)31(28)5;1-28(2)20-9-3-6-12-23(20)30(24-13-7-4-10-21(24)28)18-15-16-19(25(31)17-18)27-29-22-11-5-8-14-26(22)32-27;1-14-16(3)26(17(4)15(2)24(14,5)6)18-11-12-19(21(27)13-18)23-25-20-9-7-8-10-22(20)28-23;1-14-16(3)28(17(4)15(2)26(14)5)18-11-12-19(20(24)13-18)23-25-21-9-7-8-10-22(21)27(23)6;2*1-13-15(3)26(16(4)14(2)25(13)5)17-10-11-18(19(23)12-17)22-24-20-8-6-7-9-21(20)27-22;;;;;/h6-17,19-30,32H,2-5,18,31H2,1H3;7-15,17-26,28H,3-6,16,27H2,1-2H3;2*7-12,14-21,23H,3-6,13,22H2,1-2H3;6-17H,29H2,1-5H3;3-17,31H,1-2H3;7-13,27H,1-6H3;7-13H,24H2,1-6H3;2*6-12H,23H2,1-5H3;;;;;/q4*-1;;;;;;;;;;;.

What are the key properties of [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc?

[2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc has a molecular weight of 4900.98 g/mol, XLogP of 81.44, 52 rotatable bonds, 6 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for [2-(1,3-benzothiazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzothiazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1,3-benzoxazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenol;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,4,5,6-hexamethyl-1-pyridinyl)phenol;[2-(1,3-benzoxazol-2-yl)-5-(10-methylphenazin-5-yl)phenyl]-heptylazanide;2-(1,3-benzoxazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;heptyl-[5-(10-methylphenazin-5-yl)-2-(1-phenylbenzimidazol-2-yl)phenyl]azanide;heptyl-[2-(1-phenylbenzimidazol-2-yl)-5-(10-phenylphenazin-5-yl)phenyl]azanide;2-(1-methylbenzimidazol-2-yl)-5-(2,3,4,5,6-pentamethylpyrazin-1-yl)aniline;2-(1-methylbenzimidazol-2-yl)-5-(2,3,5,6-tetramethyl-4-phenylpyrazin-1-yl)aniline;zinc is sourced from PubChem (CID 157141553), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).